LINC00665 and acute myeloid leukemia: The data from TCGA and GTEx revealed that LINC00665 was significantly differentially expressed in breast invasive carcinoma, cholangiocarcinoma, colon adenocarcinoma, lymphoid neoplasm diffuse large B-cell lymphoma, head and neck squamous cell carcinoma, acute myeloid leukemia, liver hepatocellular carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, ovarian serous cystadenocarcinoma, rectum adenocarcinoma, stomach adenocarcinoma, testicular germ cell tumors, thymoma, and uterine carcinosarcoma (Figure 3).